Summary
There is an urgent need for new drugs and treatments to address a range of illnesses in infants, children, and adolescents, yet including these vulnerable populations in clinical research raises a number of ethical issues that are important to address. This event will explore key ethical considerations regarding the research participation of those who have not attained the legal age for consent to treatments or procedures involved in biomedical studies. Discussions will center on addressing consent, assent, and privacy in pediatric research, study design and regulatory issues, small sample size studies in genomics and rare disease research, health disparities, Covid-19 research in children, broad population-based disease prevention efforts, and will close with a look to the future of pediatric research.
Colloquium Conflict Management
The New York Academy of Sciences is a neutral convener of scientific symposia. We adhere to Accreditation Council for Continuing Medical Education (ACCME) principles for all of our programming. Please note that Johnson & Johnson is a sponsor of this convening, and The New York Academy of Sciences and NYU Grossman School of Medicine exercise full control over the planning of the program’s content, the selection of speakers and all enduring materials.
Registration
This event has been completed.